95.03
-2.42
(-2.48%)
Real-time:
2:40PM EDT
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 95.02 - 98.07 |
| 52 week | 74.77 - 99.68 |
| Open | 97.80 |
| Vol / Avg. | 144,489.00/261,299.00 |
| Mkt cap | 1.55B |
| P/E | - |
| Div/yield | - |
| EPS | -5.69 |
| Shares | 16.35M |
| Beta | -0.29 |
| Inst. own | 104% |
Events
Aug 14, 2013
HeartWare International at Canaccord Genuity Growth Conference
Aug 5, 2013
Q2 2013 HeartWare International Earnings Release
Jun 18, 2013
HeartWare International at Wells Fargo Health Care Conference
Jun 12, 2013
HeartWare International at Goldman Sachs Healthcare Conference
May 21, 2013
HeartWare International Annual General Meeting
- 5:00PM EDT -
May 20, 2013
HeartWare International at UBS Global Healthcare Conference -
May 16, 2013
HeartWare International at Bank of America Merrill Lynch Health Care Conference -
May 6, 2013
Q1 2013 HeartWare International Earnings Release
Apr 29, 2013
Q1 2013 HeartWare International Earnings Conference Call -
Mar 5, 2013
HeartWare International at Raymond James Institutional Investors Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | -26.32% | -79.08% |
| Operating margin | -16.59% | -69.95% |
| EBITD margin | - | -65.42% |
| Return on average assets | -19.09% | -39.23% |
| Return on average equity | -38.47% | -89.97% |
| Employees | 396 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite 101, 205 Newbury Street
FRAMINGHAM, MA 01701
United States - Map
+1-508-7390950 (Phone)
+1-508-7390948 (Fax)
FRAMINGHAM, MA 01701
United States - Map
+1-508-7390950 (Phone)
+1-508-7390948 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Heartware International, Inc. (HeartWare) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure. The HeartWare Ventricular Assist System (the HeartWare System), which includes a ventricular assist device (VAD), or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients in the advanced stage of heart failure. The core of the HeartWare System is a continuous flow blood pump, the HVAD Pump, which is a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices. In August 2012, it acquired World Heart Corporation. As of December 31, 2012, the HeartWare System has been implanted outside of the United States at approximately 168 health care sites in 28 countries.
Officers and directors
| Douglas Evan Godshall | President, Chief Executive Officer, Director | |
| Peter F. McAree | Chief Financial Officer, Senior Vice President, Treasurer | |
| Jeffrey A. LaRose | Executive Vice President, Chief Scientific Officer | |
| Lawrence Knopf | Senior Vice President, General Counsel, Company Secretary | |
| James Schuermann | Senior Vice President - Sales and Marketing | |
| Robert Yocher | Senior Vice President - Regulatory & Quality Assurance | |
| David R. Hathaway | Chief Medical Officer | |
| C. Raymond Larkin Jr. | Non-Executive Independent Chairman of the Board | |
| Seth Loring Harrison M.D. | Non-Executive Deputy Chairman of the Board | |
| Cynthia L. Feldmann | Independent Director |